_id
6915f314bc934aba376b21a4
Ticker
RYTM
Name
Rhythm Pharmaceuticals Inc
Exchange
NASDAQ
Address
222 Berkeley Street, Boston, MA, United States, 02116
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://rhythmtx.com
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.
Last Close
117.62
Volume
660230
Current Price
113.56
Change
-3.4517939125999
Last Updated
2025-12-03T13:15:15.362Z
Image
data:image/webp;base64,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
Ipo Date
2017-10-05T00:00:00.000Z
Market Cap
6766368768
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.6537388888888889
Sentiment Sources
18
Rating
4.6667
Target Price
127
Strong Buy
8
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
51298000
Cost Of Revenue
5499000
Gross Profit
45799000
Operating Expenses
98452000
Operating Income
-52653000
Interest Expense
4742000
Pretax Income
-52793000
Net Income
-52904000
Eps
-0.8221725758015328
Dividends Per Share
1375000
Shares Outstanding
66736056
Income Tax Expense
111000
EBITDA
-47747000
Operating Margin
-102.64142851573162
Total Other Income Expense Net
-140000
Cash
52078000
Short Term Investments
363974000
Receivables
33034000
Inventories
22107000
Total Current Assets
494802000
Property Plant Equipment
3395000
Total Assets
506874000
Payables
13631000
Short Term Debt
624000
Long Term Debt
-
Total Liabilities
358057000
Equity
148817000
Depreciation
304000
Change In Working Capital
-7908000
Cash From Operations
-26622000
Capital Expenditures
0
Cash From Investing
-246347000
Cash From Financing
189301000
Net Change In Cash
-83364000
PE
-
PB
49.101907263820664
ROE
-35.54970198297237
ROA
-10.43730789111298
FCF
-26622000
Fcf Percent
-0.5189676010760653
Piotroski FScore
1
Health Score
13
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
51298000
Quarters > 0 > income Statement > cost Of Revenue
5499000
Quarters > 0 > income Statement > gross Profit
45799000
Quarters > 0 > income Statement > operating Expenses
98452000
Quarters > 0 > income Statement > operating Income
-52653000
Quarters > 0 > income Statement > interest Expense
4742000
Quarters > 0 > income Statement > pretax Income
-52793000
Quarters > 0 > income Statement > net Income
-52904000
Quarters > 0 > income Statement > eps
-0.8221725758015328
Quarters > 0 > income Statement > dividends Per Share
1375000
Quarters > 0 > income Statement > shares Outstanding
64346588
Quarters > 0 > income Statement > income Tax Expense
111000
Quarters > 0 > income Statement > EBITDA
-47747000
Quarters > 0 > income Statement > operating Margin
-102.64142851573162
Quarters > 0 > income Statement > total Other Income Expense Net
-140000
Quarters > 0 > balance Sheet > cash
52078000
Quarters > 0 > balance Sheet > short Term Investments
363974000
Quarters > 0 > balance Sheet > receivables
33034000
Quarters > 0 > balance Sheet > inventories
22107000
Quarters > 0 > balance Sheet > total Current Assets
494802000
Quarters > 0 > balance Sheet > property Plant Equipment
3395000
Quarters > 0 > balance Sheet > total Assets
506874000
Quarters > 0 > balance Sheet > payables
13631000
Quarters > 0 > balance Sheet > short Term Debt
624000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
358057000
Quarters > 0 > balance Sheet > equity
148817000
Quarters > 0 > cash Flow > net Income
-52904000
Quarters > 0 > cash Flow > depreciation
304000
Quarters > 0 > cash Flow > change In Working Capital
-7908000
Quarters > 0 > cash Flow > cash From Operations
-26622000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-246347000
Quarters > 0 > cash Flow > cash From Financing
189301000
Quarters > 0 > cash Flow > net Change In Cash
-83364000
Quarters > 0 > ratios > PE
-0.8221725758015328
Quarters > 0 > ratios > PB
49.101907263820664
Quarters > 0 > ratios > ROE
-35.54970198297237
Quarters > 0 > ratios > ROA
-10.43730789111298
Quarters > 0 > ratios > FCF
-26622000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.5189676010760653
Quarters > 0 > health Score
13
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
48502000
Quarters > 1 > income Statement > cost Of Revenue
5543000
Quarters > 1 > income Statement > gross Profit
42959000
Quarters > 1 > income Statement > operating Expenses
88255000
Quarters > 1 > income Statement > operating Income
-45296000
Quarters > 1 > income Statement > interest Expense
5817000
Quarters > 1 > income Statement > pretax Income
-46295000
Quarters > 1 > income Statement > net Income
-46632000
Quarters > 1 > income Statement > eps
-0.732236309389563
Quarters > 1 > income Statement > dividends Per Share
2671000
Quarters > 1 > income Statement > shares Outstanding
63684359
Quarters > 1 > income Statement > income Tax Expense
337000
Quarters > 1 > income Statement > EBITDA
-40099000
Quarters > 1 > income Statement > operating Margin
-93.38996330048246
Quarters > 1 > income Statement > total Other Income Expense Net
-999000
Quarters > 1 > balance Sheet > cash
135586000
Quarters > 1 > balance Sheet > short Term Investments
155444000
Quarters > 1 > balance Sheet > receivables
26122000
Quarters > 1 > balance Sheet > inventories
18872000
Quarters > 1 > balance Sheet > total Current Assets
360680000
Quarters > 1 > balance Sheet > property Plant Equipment
3559000
Quarters > 1 > balance Sheet > total Assets
372733000
Quarters > 1 > balance Sheet > payables
15982000
Quarters > 1 > balance Sheet > short Term Debt
4288000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
384641000
Quarters > 1 > balance Sheet > equity
-11908000
Quarters > 1 > cash Flow > net Income
-46632000
Quarters > 1 > cash Flow > depreciation
379000
Quarters > 1 > cash Flow > change In Working Capital
4525000
Quarters > 1 > cash Flow > cash From Operations
-23313000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
54035000
Quarters > 1 > cash Flow > cash From Financing
-889000
Quarters > 1 > cash Flow > net Change In Cash
29554000
Quarters > 1 > ratios > PE
-0.732236309389563
Quarters > 1 > ratios > PB
-607.3224561672826
Quarters > 1 > ratios > ROE
391.60228417870337
Quarters > 1 > ratios > ROA
-12.510832150627929
Quarters > 1 > ratios > FCF
-23313000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.480660591315822
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
32704000
Quarters > 2 > income Statement > cost Of Revenue
3648000
Quarters > 2 > income Statement > gross Profit
29056000
Quarters > 2 > income Statement > operating Expenses
76060000
Quarters > 2 > income Statement > operating Income
-47004000
Quarters > 2 > income Statement > interest Expense
5409000
Quarters > 2 > income Statement > pretax Income
-49418000
Quarters > 2 > income Statement > net Income
-49498000
Quarters > 2 > income Statement > eps
-0.7849474301844305
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
63059000
Quarters > 2 > income Statement > income Tax Expense
80000
Quarters > 2 > income Statement > EBITDA
-43626000
Quarters > 2 > income Statement > operating Margin
-143.72553816046968
Quarters > 2 > income Statement > total Other Income Expense Net
-2414000
Quarters > 2 > balance Sheet > cash
106095000
Quarters > 2 > balance Sheet > short Term Investments
208393000
Quarters > 2 > balance Sheet > receivables
17825000
Quarters > 2 > balance Sheet > inventories
19316000
Quarters > 2 > balance Sheet > total Current Assets
369288000
Quarters > 2 > balance Sheet > property Plant Equipment
3829000
Quarters > 2 > balance Sheet > total Assets
386685000
Quarters > 2 > balance Sheet > payables
11912000
Quarters > 2 > balance Sheet > short Term Debt
224000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
223596000
Quarters > 2 > balance Sheet > equity
163089000
Quarters > 2 > cash Flow > net Income
-49498000
Quarters > 2 > cash Flow > depreciation
383000
Quarters > 2 > cash Flow > change In Working Capital
-7909000
Quarters > 2 > cash Flow > cash From Operations
-40351000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
24812000
Quarters > 2 > cash Flow > cash From Financing
32499000
Quarters > 2 > cash Flow > net Change In Cash
16958000
Quarters > 2 > ratios > PE
-0.7849474301844305
Quarters > 2 > ratios > PB
43.90841834826383
Quarters > 2 > ratios > ROE
-30.35029952970464
Quarters > 2 > ratios > ROA
-12.800599971553073
Quarters > 2 > ratios > FCF
-40351000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.2338246086105675
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
41830000
Quarters > 3 > income Statement > cost Of Revenue
3787000
Quarters > 3 > income Statement > gross Profit
38043000
Quarters > 3 > income Statement > operating Expenses
79298000
Quarters > 3 > income Statement > operating Income
-41255000
Quarters > 3 > income Statement > interest Expense
5447000
Quarters > 3 > income Statement > pretax Income
-43382000
Quarters > 3 > income Statement > net Income
-43292000
Quarters > 3 > income Statement > eps
-0.7028378466134164
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
61596000
Quarters > 3 > income Statement > income Tax Expense
-90000
Quarters > 3 > income Statement > EBITDA
-37552000
Quarters > 3 > income Statement > operating Margin
-98.6253884771695
Quarters > 3 > income Statement > total Other Income Expense Net
-2127000
Quarters > 3 > balance Sheet > cash
89137000
Quarters > 3 > balance Sheet > short Term Investments
231428000
Quarters > 3 > balance Sheet > receivables
18512000
Quarters > 3 > balance Sheet > inventories
18741000
Quarters > 3 > balance Sheet > total Current Assets
374200000
Quarters > 3 > balance Sheet > property Plant Equipment
4109000
Quarters > 3 > balance Sheet > total Assets
392273000
Quarters > 3 > balance Sheet > payables
12328000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
227724000
Quarters > 3 > balance Sheet > equity
164549000
Quarters > 3 > cash Flow > net Income
-43292000
Quarters > 3 > cash Flow > depreciation
383000
Quarters > 3 > cash Flow > change In Working Capital
10208000
Quarters > 3 > cash Flow > cash From Operations
-18845000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
21157000
Quarters > 3 > cash Flow > cash From Financing
38328000
Quarters > 3 > cash Flow > net Change In Cash
41618000
Quarters > 3 > ratios > PE
-0.7028378466134164
Quarters > 3 > ratios > PB
42.509172100711645
Quarters > 3 > ratios > ROE
-26.309488359090604
Quarters > 3 > ratios > ROA
-11.03619163184823
Quarters > 3 > ratios > FCF
-18845000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.4505139851781018
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
130126000
Annuals > 0 > income Statement > cost Of Revenue
13368000
Annuals > 0 > income Statement > gross Profit
116758000
Annuals > 0 > income Statement > operating Expenses
382261000
Annuals > 0 > income Statement > operating Income
-265503000
Annuals > 0 > income Statement > interest Expense
20603000
Annuals > 0 > income Statement > pretax Income
-260256000
Annuals > 0 > income Statement > net Income
-260602000
Annuals > 0 > income Statement > eps
-4.27251414050332
Annuals > 0 > income Statement > dividends Per Share
3970000
Annuals > 0 > income Statement > shares Outstanding
60995000
Annuals > 0 > income Statement > income Tax Expense
346000
Annuals > 0 > income Statement > EBITDA
-238090000
Annuals > 0 > income Statement > operating Margin
-204.03531961329787
Annuals > 0 > income Statement > total Other Income Expense Net
5247000
Annuals > 0 > balance Sheet > cash
89137000
Annuals > 0 > balance Sheet > short Term Investments
231428000
Annuals > 0 > balance Sheet > receivables
18512000
Annuals > 0 > balance Sheet > inventories
18741000
Annuals > 0 > balance Sheet > total Current Assets
374200000
Annuals > 0 > balance Sheet > property Plant Equipment
4109000
Annuals > 0 > balance Sheet > total Assets
392273000
Annuals > 0 > balance Sheet > payables
12328000
Annuals > 0 > balance Sheet > short Term Debt
1541000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
227724000
Annuals > 0 > balance Sheet > equity
164549000
Annuals > 0 > cash Flow > net Income
-260602000
Annuals > 0 > cash Flow > depreciation
1563000
Annuals > 0 > cash Flow > change In Working Capital
10575000
Annuals > 0 > cash Flow > cash From Operations
-113879000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-48173000
Annuals > 0 > cash Flow > cash From Financing
191242000
Annuals > 0 > cash Flow > net Change In Cash
29192000
Annuals > 0 > ratios > PE
-4.27251414050332
Annuals > 0 > ratios > PB
37.58323083093789
Annuals > 0 > ratios > ROE
-158.3734936098062
Annuals > 0 > ratios > ROA
-66.43383561958126
Annuals > 0 > ratios > FCF
-113879000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.8751440911116918
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
77428000
Annuals > 1 > income Statement > cost Of Revenue
9302000
Annuals > 1 > income Statement > gross Profit
68126000
Annuals > 1 > income Statement > operating Expenses
252483000
Annuals > 1 > income Statement > operating Income
-184357000
Annuals > 1 > income Statement > interest Expense
13892000
Annuals > 1 > income Statement > pretax Income
-184114000
Annuals > 1 > income Statement > net Income
-184678000
Annuals > 1 > income Statement > eps
-3.2021498816571907
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
57673128
Annuals > 1 > income Statement > income Tax Expense
564000
Annuals > 1 > income Statement > EBITDA
-168464000
Annuals > 1 > income Statement > operating Margin
-238.1012036989203
Annuals > 1 > income Statement > total Other Income Expense Net
243000
Annuals > 1 > balance Sheet > cash
60081000
Annuals > 1 > balance Sheet > short Term Investments
215765000
Annuals > 1 > balance Sheet > receivables
14867000
Annuals > 1 > balance Sheet > inventories
8624000
Annuals > 1 > balance Sheet > total Current Assets
308268000
Annuals > 1 > balance Sheet > property Plant Equipment
2122000
Annuals > 1 > balance Sheet > total Assets
332745000
Annuals > 1 > balance Sheet > payables
4885000
Annuals > 1 > balance Sheet > short Term Debt
770000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
162986000
Annuals > 1 > balance Sheet > equity
169759000
Annuals > 1 > cash Flow > net Income
-184678000
Annuals > 1 > cash Flow > depreciation
1758000
Annuals > 1 > cash Flow > change In Working Capital
4807000
Annuals > 1 > cash Flow > cash From Operations
-136157000
Annuals > 1 > cash Flow > capital Expenditures
47000
Annuals > 1 > cash Flow > cash From Investing
-5665000
Annuals > 1 > cash Flow > cash From Financing
74368000
Annuals > 1 > cash Flow > net Change In Cash
-67596000
Annuals > 1 > ratios > PE
-3.2021498816571907
Annuals > 1 > ratios > PB
34.44576398258708
Annuals > 1 > ratios > ROE
-108.7883411188803
Annuals > 1 > ratios > ROA
-55.50135990022389
Annuals > 1 > ratios > FCF
-136204000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.7591052332489538
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
23638000
Annuals > 2 > income Statement > cost Of Revenue
2133000
Annuals > 2 > income Statement > gross Profit
21505000
Annuals > 2 > income Statement > operating Expenses
200662000
Annuals > 2 > income Statement > operating Income
-179157000
Annuals > 2 > income Statement > interest Expense
5201000
Annuals > 2 > income Statement > pretax Income
-181119000
Annuals > 2 > income Statement > net Income
-181119000
Annuals > 2 > income Statement > eps
-3.474991635281344
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
52120701
Annuals > 2 > income Statement > income Tax Expense
1962000
Annuals > 2 > income Statement > EBITDA
-174246000
Annuals > 2 > income Statement > operating Margin
-757.9194517302648
Annuals > 2 > income Statement > total Other Income Expense Net
-1962000
Annuals > 2 > balance Sheet > cash
127677000
Annuals > 2 > balance Sheet > short Term Investments
205611000
Annuals > 2 > balance Sheet > receivables
6224000
Annuals > 2 > balance Sheet > inventories
2917000
Annuals > 2 > balance Sheet > total Current Assets
354236000
Annuals > 2 > balance Sheet > property Plant Equipment
3379000
Annuals > 2 > balance Sheet > total Assets
382481000
Annuals > 2 > balance Sheet > payables
4797000
Annuals > 2 > balance Sheet > short Term Debt
684000
Annuals > 2 > balance Sheet > long Term Debt
1340000
Annuals > 2 > balance Sheet > total Liabilities
118219000
Annuals > 2 > balance Sheet > equity
264262000
Annuals > 2 > cash Flow > net Income
-181119000
Annuals > 2 > cash Flow > depreciation
1672000
Annuals > 2 > cash Flow > change In Working Capital
-19724000
Annuals > 2 > cash Flow > cash From Operations
-173428000
Annuals > 2 > cash Flow > capital Expenditures
4281000
Annuals > 2 > cash Flow > cash From Investing
28029000
Annuals > 2 > cash Flow > cash From Financing
213828000
Annuals > 2 > cash Flow > net Change In Cash
68429000
Annuals > 2 > ratios > PE
-3.474991635281344
Annuals > 2 > ratios > PB
19.99726738763046
Annuals > 2 > ratios > ROE
-68.53766337952486
Annuals > 2 > ratios > ROA
-47.35372476018417
Annuals > 2 > ratios > FCF
-177709000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-7.517937219730942
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3154000
Annuals > 3 > income Statement > cost Of Revenue
599000
Annuals > 3 > income Statement > gross Profit
2555000
Annuals > 3 > income Statement > operating Expenses
172614000
Annuals > 3 > income Statement > operating Income
-170059000
Annuals > 3 > income Statement > interest Expense
100447000
Annuals > 3 > income Statement > pretax Income
-69612000
Annuals > 3 > income Statement > net Income
-68007000
Annuals > 3 > income Statement > eps
-1.3711007438786553
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
49600294
Annuals > 3 > income Statement > income Tax Expense
-1605000
Annuals > 3 > income Statement > EBITDA
-168901000
Annuals > 3 > income Statement > operating Margin
-5391.851616994293
Annuals > 3 > income Statement > total Other Income Expense Net
100447000
Annuals > 3 > balance Sheet > cash
59248000
Annuals > 3 > balance Sheet > short Term Investments
235607000
Annuals > 3 > balance Sheet > receivables
1025000
Annuals > 3 > balance Sheet > inventories
111000
Annuals > 3 > balance Sheet > total Current Assets
308387000
Annuals > 3 > balance Sheet > property Plant Equipment
4335000
Annuals > 3 > balance Sheet > total Assets
329523000
Annuals > 3 > balance Sheet > payables
5737000
Annuals > 3 > balance Sheet > short Term Debt
606000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
45372000
Annuals > 3 > balance Sheet > equity
284151000
Annuals > 3 > cash Flow > net Income
-69612000
Annuals > 3 > cash Flow > depreciation
1158000
Annuals > 3 > cash Flow > change In Working Capital
1897000
Annuals > 3 > cash Flow > cash From Operations
-146003000
Annuals > 3 > cash Flow > capital Expenditures
5434000
Annuals > 3 > cash Flow > cash From Investing
-62159000
Annuals > 3 > cash Flow > cash From Financing
166481000
Annuals > 3 > cash Flow > net Change In Cash
-41681000
Annuals > 3 > ratios > PE
-1.3711007438786553
Annuals > 3 > ratios > PB
17.698244273854396
Annuals > 3 > ratios > ROE
-23.93340160689211
Annuals > 3 > ratios > ROA
-20.638013128066934
Annuals > 3 > ratios > FCF
-151437000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-48.0142675967026
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.8221725758015328
Valuation > metrics > PB
49.101907263820664
Valuation > final Score
20
Valuation > verdict
1536.7% Overvalued
Profitability > metrics > ROE
-35.54970198297237
Profitability > metrics > ROA
-10.691953549096405
Profitability > metrics > Net Margin
-1.0313072634410698
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.406022161446609
Risk > metrics > Interest Coverage
-11.103542808941375
Risk > final Score
-26
Risk > verdict
High
Liquidity > metrics > Current Ratio
34.710768151525784
Liquidity > metrics > Quick Ratio
33.15994387934058
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1
Prev Risks > 1
-5
Prev Risks > 2
0
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:19:36.911Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-11
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.82
Earnings History > 0 > eps Estimate
-0.6874
Earnings History > 0 > eps Difference
-0.1326
Earnings History > 0 > surprise Percent
-19.2901
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-05
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.75
Earnings History > 1 > eps Estimate
-0.67
Earnings History > 1 > eps Difference
-0.08
Earnings History > 1 > surprise Percent
-11.9403
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.81
Earnings History > 2 > eps Estimate
-2.16
Earnings History > 2 > eps Difference
1.35
Earnings History > 2 > surprise Percent
62.5
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.72
Earnings History > 3 > eps Estimate
-0.73
Earnings History > 3 > eps Difference
0.01
Earnings History > 3 > surprise Percent
1.3699
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.73
Earnings History > 4 > eps Estimate
-0.8
Earnings History > 4 > eps Difference
0.07
Earnings History > 4 > surprise Percent
8.75
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.69
Earnings History > 5 > eps Estimate
-0.71
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
2.8169
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.35
Earnings History > 6 > eps Estimate
-2.16
Earnings History > 6 > eps Difference
-0.19
Earnings History > 6 > surprise Percent
-8.7963
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.7
Earnings History > 7 > eps Estimate
-0.7
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.76
Earnings History > 8 > eps Estimate
-0.74
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-2.7027
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-01
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.82
Earnings History > 9 > eps Estimate
-0.79
Earnings History > 9 > eps Difference
-0.03
Earnings History > 9 > surprise Percent
-3.7975
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-02
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.92
Earnings History > 10 > eps Estimate
-0.73
Earnings History > 10 > eps Difference
-0.19
Earnings History > 10 > surprise Percent
-26.0274
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-01
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.75
Earnings History > 11 > eps Estimate
-0.81
Earnings History > 11 > eps Difference
0.06
Earnings History > 11 > surprise Percent
7.4074
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.79
Earnings History > 12 > eps Estimate
-1
Earnings History > 12 > eps Difference
0.21
Earnings History > 12 > surprise Percent
21
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-02
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.89
Earnings History > 13 > eps Estimate
-0.95
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
6.3158
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-03
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.05
Earnings History > 14 > eps Estimate
-1.01
Earnings History > 14 > eps Difference
-0.04
Earnings History > 14 > surprise Percent
-3.9604
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-01
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.85
Earnings History > 15 > eps Estimate
-0.91
Earnings History > 15 > eps Difference
0.06
Earnings History > 15 > surprise Percent
6.5934
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-02
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.7
Earnings History > 16 > eps Estimate
-0.81
Earnings History > 16 > eps Difference
0.11
Earnings History > 16 > surprise Percent
13.5802
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-03
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.7
Earnings History > 17 > eps Estimate
-0.68
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-2.9412
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-03
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.16
Earnings History > 18 > eps Estimate
0.3
Earnings History > 18 > eps Difference
-1.46
Earnings History > 18 > surprise Percent
-486.6667
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-01
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.79
Earnings History > 19 > eps Estimate
-0.8
Earnings History > 19 > eps Difference
0.01
Earnings History > 19 > surprise Percent
1.25
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-02
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.77
Earnings History > 20 > eps Estimate
-0.8
Earnings History > 20 > eps Difference
0.03
Earnings History > 20 > surprise Percent
3.75
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-03
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.71
Earnings History > 21 > eps Estimate
-0.83
Earnings History > 21 > eps Difference
0.12
Earnings History > 21 > surprise Percent
14.4578
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-04
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.78
Earnings History > 22 > eps Estimate
-0.84
Earnings History > 22 > eps Difference
0.06
Earnings History > 22 > surprise Percent
7.1429
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-02
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.78
Earnings History > 23 > eps Estimate
-0.89
Earnings History > 23 > eps Difference
0.11
Earnings History > 23 > surprise Percent
12.3596
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-01
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.04
Earnings History > 24 > eps Estimate
-1.07
Earnings History > 24 > eps Difference
0.03
Earnings History > 24 > surprise Percent
2.8037
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-07-29
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.24
Earnings History > 25 > eps Estimate
-0.88
Earnings History > 25 > eps Difference
-0.36
Earnings History > 25 > surprise Percent
-40.9091
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-03
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.84
Earnings History > 26 > eps Estimate
-0.76
Earnings History > 26 > eps Difference
-0.08
Earnings History > 26 > surprise Percent
-10.5263
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-08
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.74
Earnings History > 27 > eps Estimate
-0.57
Earnings History > 27 > eps Difference
-0.17
Earnings History > 27 > surprise Percent
-29.8246
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-09
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.52
Earnings History > 28 > eps Estimate
-0.46
Earnings History > 28 > eps Difference
-0.06
Earnings History > 28 > surprise Percent
-13.0435
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-08
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.52
Earnings History > 29 > eps Estimate
-0.48
Earnings History > 29 > eps Difference
-0.04
Earnings History > 29 > surprise Percent
-8.3333
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-14
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.6
Earnings History > 30 > eps Estimate
-0.45
Earnings History > 30 > eps Difference
-0.15
Earnings History > 30 > surprise Percent
-33.3333
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-12
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.41
Earnings History > 31 > eps Estimate
-0.46
Earnings History > 31 > eps Difference
0.05
Earnings History > 31 > surprise Percent
10.8696
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-14
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-1.51
Earnings History > 32 > eps Estimate
-0.4
Earnings History > 32 > eps Difference
-1.11
Earnings History > 32 > surprise Percent
-277.5
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-30
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.41
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.41
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-24
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.29
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.29
Earnings History > 34 > surprise Percent
-
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARYTM Stock: Canaccord Genuity Raises Price Target to $141, Maint GuruFocus
Read more →Goldman Sachs Raises Price Target for RYTM to $157, Maintains Buy Rating | RYTM Stock News GuruFocus
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$127
Analyst Picks
Strong Buy
8
Buy
4
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 101.85% of the total shares of Rhythm Pharmaceuticals Inc
1.
BlackRock Inc(9.4362%)
since
2025/06/30
2.
Baker Bros Advisors LP(8.4379%)
since
2025/06/30
3.
RA Capital Management, LLC(8.373%)
since
2025/06/30
4.
PRIMECAP Management Company(7.3442%)
since
2025/06/30
5.
Vanguard Group Inc(5.4037%)
since
2025/06/30
6.
PRIMECAP Odyssey Aggressive Growth(4.6538%)
since
2025/06/30
7.
NEA Management Company, LLC(4.3811%)
since
2025/06/30
8.
Perceptive Advisors LLC(3.6409%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(3.0449%)
since
2025/07/31
10.
FMR Inc(2.941%)
since
2025/06/30
11.
State Street Corp(2.872%)
since
2025/06/30
12.
Goldman Sachs Group Inc(2.6102%)
since
2025/06/30
13.
Federated Hermes Inc(2.5391%)
since
2025/06/30
14.
Westfield Capital Management Company, L.P.(2.4533%)
since
2025/06/30
15.
PRIMECAP Odyssey Growth(2.3017%)
since
2025/06/30
16.
HHG PLC(2.1257%)
since
2025/06/30
17.
T. Rowe Price Associates, Inc.(2.0196%)
since
2025/06/30
18.
iShares Russell 2000 ETF(1.9772%)
since
2025/08/31
19.
Geode Capital Management, LLC(1.9742%)
since
2025/06/30
20.
Driehaus Capital Management LLC(1.912%)
since
2025/06/30
21.
Polar Capital Holdings PLC(1.8833%)
since
2025/06/30
22.
Polar Capital Biotech S Inc(1.882%)
since
2025/07/31
23.
Checkpoint Capital LP(1.5959%)
since
2025/06/30
24.
Alkeon Capital Management, LLC(1.5322%)
since
2025/06/30
25.
Rock Springs Capital Management LP(1.2965%)
since
2025/06/30
26.
Federated Hermes Kaufmann Small Cap Grow(1.1171%)
since
2025/06/30
27.
Federated Hermes Kaufmann Small Cap A(1.1171%)
since
2025/06/30
28.
Federated Hermes Kaufmann Growth(1.1036%)
since
2025/06/30
29.
Federated Hermes Kaufmann R(1.1036%)
since
2025/06/30
30.
BlackRock Health Sciences Opps Inv A(1.0394%)
since
2025/07/31
31.
SPDR® S&P Biotech ETF(0.9485%)
since
2025/08/31
32.
BGF World Healthscience A2(0.9205%)
since
2025/05/31
33.
Vanguard Institutional Extnd Mkt Idx Tr(0.8745%)
since
2025/07/31
34.
Fidelity Small Cap Growth(0.8693%)
since
2025/06/30
35.
Fidelity Small Cap Index(0.8218%)
since
2025/06/30
36.
ACAP Strategic A(0.757%)
since
2025/06/30
37.
iShares Russell 2000 Growth ETF(0.7203%)
since
2025/08/31
38.
T. Rowe Price New Horizons(0.6762%)
since
2025/07/31
39.
US Small-Cap Growth II Equity Comp(0.5811%)
since
2025/06/30
40.
JPMorgan Small Cap Growth A(0.5699%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.82
EPS Estimate
-0.6874
EPS Difference
-0.1326
Surprise Percent
-19.2901%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.